You are applying to be part of the Novartis Talent Pool. We are not currently recruiting for this role but we are building a pipeline for future opportunities. If you would like to be considered for a similar position in future, then please submit your CV.
The Novartis Group of Companies are Equal Opportunity Employers and take pride in maintaining a diverse environment. We do not discriminate in recruitment, hiring, training, promotion or other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, gender identity or expression, marital or veteran status, disability, or any other legally protected status. We are committed to building diverse teams, representative of the patients and communities we serve, and we strive to create an inclusive workplace that cultivates bold innovation through collaboration and empowers our people to unleash their full potential.
Areas of Responsibilities:
(1) Analysis of PTI campaign to inform recommendations for 2022 tactical plans. Gather and synthesize data from range of sources (digital performance, social media, Quid, advisory boards, etc...) to provide a comprehensive picture of areas for disease ed campaign is performing well, and areas for improvement. Assuming enough time in market this will be across both HCP and patient/caregiver campaigns. Based on analysis form recommendations for optimization and next stages of campaign, including content and channels and levels of investment.
(2) Work clearly with BEO to develop training curriculum for sales force, in preparation for launch. This can include modules, webinars, preceptorships, and other innovative ideas to ensure deep base of knowledge, excitement, and readiness for sales reps.
(3) Prepare for ESMO Lung / Canakinumab internal “Town Hall”. Plan for a highly energizing internal meeting in conjunction with ESMO. Coordinate across Lung Franchise, with a focus on Canakinumab content. Will need to plan for both virtual and in-person scenarios, depending on ESMO and NVS policies.